EUVIMEDEUVIMED entdecken
Crossref

Newcastle Disease Virus Vaccine Strain H as a Potential Oncolytic Agent in Ovarian Cancer Therapy

V A Sarkisova, S Sh Karshieva, A A Makarova, D O Neymysheva, P M Chumakov

Молекулярная биология / Molecular Biology · 2025 · 59 (6) · 979

DOI: 10.7868/s3034555325060086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Молекулярная биология / Molecular Biology, 2025. Verfasst von V A Sarkisova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991 Russia. Hauptthemen laut MEDLINE: Newcastle disease virus, Ovarian Neoplasms, Oncolytic Virotherapy, Oncolytic Viruses.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer remains one of the most lethal malignancies with a five-year survival rate around 20% at III–IV stages, which determines the urgent need to develop new therapeutic approaches. Newcastle disease virus (NDV) demonstrated considerable promise as an oncolytic agent, capable of selectively lysing tumor cells, suppressing the metastatic potential and stimulating anti-tumor immunity. Despite the established therapeutic potential, studies that investigate oncolytic properties of this virus within the context of ovarian cancer remain limited. In this work, we evaluated oncolytic activity of the NDV vaccine strain H in SC-OV-3, TOV-21G and OV-90 ovarian cancer cell lines. Such parameters as ability to support viral replication and cell viability after infection were investigated. As a result, all three lines were permissive to NDV-H infection. Therapeutic efficacy in vivo was assessed using a model of TOV-21G subcutaneous xenografts in BALB/c nude mice. Upon intravenous administration of the virus, a statistically significant reduction in tumor volume was observed compared to the control group. Based on these results, NDV-H strain can be considered as a potential oncolytic agent for the treatment of ovarian cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Newcastle disease virusOvarian NeoplasmsOncolytic VirotherapyOncolytic VirusesCancer VaccinesViral VaccinesFemaleAnimalsHumansMiceCell Line, TumorXenograft Model Antitumor AssaysMice, NudeVirus ReplicationMice, Inbred BALB C

Stichwörter der Autor:innen

Newcastle disease virusoncolytic virusesovarian cancervirotherapy

Substanzen

Cancer VaccinesViral Vaccines

Autor:innen und Institutionen

  • Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991 Russia.
  • Biology Faculty, Moscow State University, Moscow, 119234 Russia.
  • Blokhin National Medical Research Center of Oncology of the Ministry of Health, Moscow, 115478 Russia.
  • chumakovpm@yahoo.com.

Zitieren

APA

Sarkisova, V. A., Karshieva, S. S., A Makarova, A., Neymysheva, D. O., & Chumakov, P. M. (2025). Newcastle Disease Virus Vaccine Strain H as a Potential Oncolytic Agent in Ovarian Cancer Therapy. Молекулярная биология / Molecular Biology, 59(6), 979. https://doi.org/10.7868/s3034555325060086

Vancouver

Sarkisova VA, Karshieva SS, A Makarova A, Neymysheva DO, Chumakov PM. Newcastle Disease Virus Vaccine Strain H as a Potential Oncolytic Agent in Ovarian Cancer Therapy. Молекулярная биология / Molecular Biology. 2025;59(6):979. doi:10.7868/s3034555325060086

BibTeX
@article{Sarkisova2025,
  author = {Sarkisova, V A and Karshieva, S Sh and A Makarova, A and Neymysheva, D O and Chumakov, P M},
  title = {Newcastle Disease Virus Vaccine Strain H as a Potential Oncolytic Agent in Ovarian Cancer Therapy},
  journal = {Молекулярная биология / Molecular Biology},
  year = {2025},
  volume = {59},
  number = {6},
  pages = {979},
  doi = {10.7868/s3034555325060086}
}
Kostenlos starten →